4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-07-035734
$FOLDCIK 0001178879operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 10:43 AM ET
Size
24.5 KB
Accession
0001209191-07-035734
Insider Transaction Report
Form 4
QUAKER BIO VENTURES LP
10% Owner
Transactions
- Conversion
Common Stock
2007-06-05+1,064,822→ 1,064,822 total - Conversion
Common Stock
2007-06-05+354,940→ 1,419,762 total(indirect: By Garden State Life Sciences Venture Fund, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−135,586→ 0 totalFrom: 2006-09-13→ Common Stock (135,586 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−132,275→ 0 total(indirect: By Garden State Life Sciences Venture Fund, L.P.)From: 2005-08-16→ Common Stock (132,275 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−396,825→ 0 totalFrom: 2005-08-16→ Common Stock (396,825 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−45,195→ 0 total(indirect: By Garden State Life Sciences Venture Fund, L.P.)From: 2006-09-13→ Common Stock (45,195 underlying)
Footnotes (2)
- [F1]Each of the Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Amicus Therapeutics, Inc. common stock on a one for one basis upon the closing of Amicus Therapeutics, Inc's initial public offering on June 5, 2007.
- [F2]These shares are owned by Garden State Life Sciences Venture Fund L.P., which is under common control with Quaker BioVentures, L.P. Quaker BioVentures Capital, L.P. serves as the general partner of Quaker BioVentures, L.P. and Garden State Life Sciences Venture Fund L.P. and is the indirect beneficial owner of these shares. Quaker Bioventures Capital LLC serves as the general partner of Quaker Bioventures Capital, L.P. and is also an indirect beneficial owner of these shares. Quaker BioVentures, L.P. disclaims beneficial ownership of these shares except to the extent of its proportionate pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of section 16 of for any other purpose.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 10:43 AM ET
- Size
- 24.5 KB